Additionally, AIM2 was an independent predictor of major adverse cardiovascular events (hazard ratio, 1.453; 95% CI, 1.086-1.945; p = 0.012), and CAD patients with high AIM2 levels (>4.9 ng/mL) had a markedly lower survival rate (log-rank p = 0.040). This evidence concerns the gene AIM2 and coronary artery disorder.